Drugs / Regulatory T-cell enriched infusion
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05095649 | Mar 2022 → Aug 2025 | chronic graft versus host disease | Andalusian Public Foundation for Health Research in Seville | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Regulatory T-cell enriched infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05095649 ↗ |
| Modality | Cell therapy | “donor regulatory enriched T cells” NCT05095649 ↗ |